CDK9 and cancer: In some types of cancer including ovarian cancer, pancreatic cancer, breast cancer, and osteosarcoma, on the other hand, P-TEFb expression (CDK9 and/or CycT1) is aberrantly upregulated [201,202,203,204,205], resulting in global stimulation of P-TEFb-dependent transcription.